Antibiotics could help prevent and cure PTSD
- A drug used to treat bacterial infections could help prevent and cure PTSD
- Doxycycline works by blocking certain proteins outside nerve cells, which our brains need to form memories
- A trial showed that people on the pill had a 60 percent lower fear response
- The drug could be among the first to cure symptoms rather than just treat them
Mary Kekatos For Dailymail.com
View
comments
Antibiotics could help prevent and cure people suffering from PTSD, a new study reveals.
Researchers say a common drug called doxycycline – used to treat bacterial infections – can disrupt the formation of negative thoughts and fears in the brain.
The antibiotic works by blocking certain proteins outside nerve cells, called matrix enzymes, which our brains need to form memories.
The medication could be among the first to cure the symptoms of the disorder rather than just treat them.
New research has shown a common antibiotic could help treat or even cure people suffering from PTSD by blocking certain proteins outside nerve cells, which our brains need to form memories (file image)
Post-traumatic stress disorder, or PTSD, is caused by an overactive fear memory and includes a broad range of psychological symptoms that can develop after someone goes through a traumatic event.
About 70 percent of US adults – 223.4 million people – have experienced some type of traumatic event at least once in their lives.
And an estimated eight percent of Americans, or 24.4 million people, have PTSD at any given time.
-
‘My upbringing broke me’: Woman raised inside notorious…
PTSD treatment needs to be overhauled to address physical…
In a joint-trial held by University College London, in England, and the University of Zurich, in Switzerland, 76 healthy volunteers were given either the drug or a placebo dummy pill.
The researchers found that those who were on doxycycline had a 60 percent lower fear response than those who were not.
‘We have demonstrated a proof-of-principle for an entirely new treatment strategy for PTSD,’ said Dr Dominik Bach, a professor at University College London and the University of Zurich, who co-led the research team.
In the trial, volunteers were given either doxycycline or a placebo and put in front of a computer.
The screen would flash either blue or red, and one of the colors was associated with a 50 percent chance of getting a painful electric shock.
After 160 flashes with the colors in random order, participants learned to associate the ‘bad’ color with the shock.
A week later, under no medication, the volunteers repeated the experiment. This time there were no electric shocks, but a loud sound played after either color was shown.
Fear responses were measured by tracking eye blinks because they are an instinctive response to sudden threats.
The fear memory was calculated by subtracting the response to the sound on the ‘good’ color from the response to the sound when the ‘bad’ color was shown.
While the fear response was 60 percent lower in those who had doxycycline in the first session, the researchers also found that other cognitive measures – such as sensory memory and attention – were not affected.
‘When we talk about reducing fear memory, we’re not talking about deleting the memory of what actually happened,’ Dr Bach said.
‘The participants may not forget that they received a shock when the screen was red, but they ‘forget’ to be instinctively scared when they next see a red screen.
‘Learning to fear threats is an important ability in…helping us to avoid dangers. [But] over-prediction of threat can cause tremendous suffering and distress in anxiety disorders such as PTSD.’
Dr Bach said he and his team would next like to explore doxycycline’s potential effects further, including in a phenomenon called ‘reconsolidation’ of fear memories.
This approach to helping people with PTSD attempts to change memories and associations after an event when the patient experiences or imagines similar situations.
Share or comment on this article
- Suge Knight claims his ex-wife and former Death Row…
- Paul Burrell weeps with joy as he marries his ‘soulmate’…
- Inside the toxic court of Charles: How the Prince dropped…
- Moment police arrest ‘barbaric’ burglars who were jailed…
- Photo of Michelle Obama goes viral as internet praises…
- EXCLUSIVE: Hedge fund millionaire who plunged to his…
- Dog breeder calls out to his family as he is held in…
- Back to the scene of the crime! Peru Two drugs mule…
- Sushi chef suicide bomber patrolled St Petersburg for two…
- Husband and wife who kept a disabled woman as a sex slave…
- Mother whose son, four, died from a brain tumour is…
- Heartbroken father killed himself just days after his…
- Royal Navy chase armed Spanish gunboat out of British…
- Why I fear these two men could press the nuclear button:…
- Dog owner watches in horror as a crocodile EATS her puppy…
- Assad gasses kids with SARIN: At least 11 children among…
- Revealed: Mother killed in St Petersburg bombing saved…
- State Department insiders have discussed Susan Rice’s…
Comments 0
Share what you think
No comments have so far been submitted. Why not be the first to send us your thoughts,
or debate this issue live on our message boards.
Close
Your comment will be posted to MailOnline as usual.
Your comment will be credited to your MailOnline persona.
Close
Your comment will be posted to MailOnline as usual
We will automatically post your comment and a link to the news story to your Facebook timeline at the same time it is posted on MailOnline. To do this we will link your MailOnline account with your Facebook account. We’ll ask you to confirm this for your first post to Facebook.
The post will be credited to your MailOnline username. You can choose on each post whether you would like it to be posted to Facebook. Your details from Facebook will be used to provide you with tailored content, marketing and ads in line with our Privacy Policy.